Northern Trust Corp Avid Bioservices, Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 642,176 shares of CDMO stock, worth $8.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
642,176
Previous 646,708 0.7%
Holding current value
$8.02 Million
Previous $7.36 Million 7.76%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$9.96 - $12.36 $45,138 - $56,015
-4,532 Reduced 0.7%
642,176 $7.93 Million
Q3 2024

Nov 13, 2024
SELL
$6.7 - $12.45 $132,231 - $245,713
-19,736 Reduced 2.96%
646,708 $7.36 Million
Q2 2024

Aug 14, 2024
SELL
$6.34 - $9.28 $131,485 - $192,457
-20,739 Reduced 3.02%
666,444 $4.76 Million
Q1 2024

May 14, 2024
SELL
$5.86 - $8.79 $20,468 - $30,703
-3,493 Reduced 0.51%
687,183 $4.6 Million
Q4 2023

Feb 13, 2024
SELL
$4.64 - $9.56 $8,468 - $17,447
-1,825 Reduced 0.26%
690,676 $4.49 Million
Q3 2023

Nov 13, 2023
BUY
$9.4 - $14.04 $16,553 - $24,724
1,761 Added 0.25%
692,501 $6.54 Million
Q2 2023

Aug 11, 2023
BUY
$12.96 - $20.93 $302,784 - $488,987
23,363 Added 3.5%
690,740 $9.65 Million
Q1 2023

May 15, 2023
SELL
$13.48 - $18.79 $60,471 - $84,291
-4,486 Reduced 0.67%
667,377 $12.5 Million
Q4 2022

Feb 13, 2023
BUY
$12.61 - $18.74 $177,964 - $264,477
14,113 Added 2.15%
671,863 $9.25 Million
Q3 2022

Nov 14, 2022
BUY
$15.33 - $20.36 $5,886 - $7,818
384 Added 0.06%
657,750 $12.6 Million
Q2 2022

Aug 12, 2022
SELL
$11.63 - $21.55 $81,351 - $150,742
-6,995 Reduced 1.05%
657,366 $10 Million
Q1 2022

May 13, 2022
SELL
$16.63 - $27.73 $1.7 Million - $2.84 Million
-102,435 Reduced 13.36%
664,361 $13.5 Million
Q4 2021

Feb 08, 2022
BUY
$20.7 - $34.18 $1.26 Million - $2.08 Million
60,928 Added 8.63%
766,796 $22.4 Million
Q3 2021

Nov 15, 2021
SELL
$19.05 - $28.32 $430,758 - $640,371
-22,612 Reduced 3.1%
705,868 $15.2 Million
Q2 2021

Aug 13, 2021
BUY
$18.93 - $25.65 $1.35 Million - $1.83 Million
71,241 Added 10.84%
728,480 $18.7 Million
Q1 2021

May 12, 2021
SELL
$11.86 - $21.77 $119,797 - $219,898
-10,101 Reduced 1.51%
657,239 $12 Million
Q4 2020

Feb 11, 2021
SELL
$7.25 - $11.76 $34,785 - $56,424
-4,798 Reduced 0.71%
667,340 $7.7 Million
Q3 2020

Nov 16, 2020
SELL
$6.53 - $8.6 $166,116 - $218,775
-25,439 Reduced 3.65%
672,138 $5.12 Million
Q2 2020

Aug 14, 2020
BUY
$4.11 - $6.78 $96,350 - $158,943
23,443 Added 3.48%
697,577 $4.58 Million
Q1 2020

May 14, 2020
BUY
$3.15 - $7.39 $79,959 - $187,587
25,384 Added 3.91%
674,134 $3.45 Million
Q4 2019

Feb 14, 2020
BUY
$5.01 - $8.16 $25,741 - $41,926
5,138 Added 0.8%
648,750 $4.98 Million
Q3 2019

Nov 13, 2019
BUY
$5.07 - $7.08 $231,359 - $323,081
45,633 Added 7.63%
643,612 $3.41 Million
Q2 2019

Aug 13, 2019
BUY
$3.43 - $5.6 $57,332 - $93,604
16,715 Added 2.88%
597,979 $3.35 Million
Q1 2019

May 13, 2019
SELL
$3.56 - $4.82 $70,128 - $94,949
-19,699 Reduced 3.28%
581,264 $2.47 Million
Q4 2018

Feb 12, 2019
SELL
$4.04 - $6.75 $75,576 - $126,272
-18,707 Reduced 3.02%
600,963 $2.46 Million
Q3 2018

Nov 14, 2018
BUY
$4.28 - $7.32 $217,355 - $371,738
50,784 Added 8.93%
619,670 $4.25 Million
Q2 2018

Aug 14, 2018
BUY
$3.1 - $3.93 $1.4 Million - $1.78 Million
451,916 Added 386.35%
568,886 $2.23 Million
Q1 2018

May 09, 2018
BUY
$2.32 - $4.22 $271,370 - $493,613
116,970 New
116,970 $342,000

Others Institutions Holding CDMO

# of Institutions
209
Shares Held
67.1M
Call Options Held
216K
Put Options Held
4.6K
View Full List

About Avid Bioservices, Inc.

CDMO Quotes by TradingView
  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email